Erik Haaf

Erik Haaf is an accomplished professional in quality control and bioanalytics, currently serving as Head of Quality Control at Neovii since November 2020 and previously in similar roles at Gehrlicher Pharmazeutische Extrakte GmbH and Bayer. With a robust background in managing GLP/GCP compliant laboratories and project oversight, Erik has led teams in method development, validation, and bioanalysis of complex biomolecules. Erik's expertise spans various applied technologies including (nano)HPLC and mass spectrometry, and includes significant contributions as a principal investigator in GLP-toxicology studies. Educationally, Erik holds a Ph.D. in Analytical Chemistry from Humboldt-Universität zu Berlin and has completed pharmacy degrees from Johannes Gutenberg University Mainz and Heidelberg University.